Table 5

The risk of visceral adiposity measured by ultrasound in the presence or absence of cardiometabolic dysfunction on recurrent vascular events and mortality

Events/nAge and sex adjusted HRMultivariable adjusted HR*
Major cardiovascular events
Lowest tertile
 Without CMD54/93711
 With CMD49/4631.70 (1.16 to 2.51)1.44 (0.97 to 2.12)
Intermediate tertile
 Without CMD43/6401.10 (0.74 to 1.64)1.10 (0.73 to 1.64)
 With CMD84/7321.91 (1.36 to 2.69)1.60 (1.13 to 2.26)
Highest tertile
 Without CMD33/4251.24 (0.80 to 1.91)1.23 (0.80 to 1.91)
 With CMD138/10222.07 (1.51 to 2.84)1.70 (1.24 to 2.35)
All-cause mortality
Lowest tertile
 Without CMD43/93711
 With CMD52/4632.24 (1.49 to 3.35)1.75 (1.16 to 2.63)
Intermediate tertile
 Without CMD51/6401.56 (1.04 to 2.34)1.53 (1.02 to 2.29)
 With CMD72/7322.00 (1.37 to 2.91)1.62 (1.11 to 2.38)
Highest tertile
 Without CMD39/4251.72 (1.11 to 2.65)1.66 (1.08 to 2.57)
 With CMD133/10222.21 (1.57 to 3.12)1.73 (1.22 to 2.46)
  • CMD, cardiometabolic dysfunction (≥3 risk factors). Risk factors: (i) elevated blood pressure (≥130 mm Hg SBP and/or ≥85 mm Hg DBP, (ii) hypertriglyceridaemia (≥1.70 mmol/L), (iii) low HDL (<1.03 mmol/L for men and <1.30 for women), (iv) high fasting glucose (>5.6 mmol/L) and (v) elevated hsCRP (≥2 mg/L).

  • *Multivariable model adjusted for age, sex, smoking status, alcohol consumption, physical activity, use of lipid lowering agents, use of anti-platelet agents, number of affected vascular territories and years since first vascular event.

  • †Major cardiovascular events is a composite of stroke, myocardial infarction, retinal infarction and vascular mortality.

  • hsCRP, high-sensitivity C-reactive protein.